[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ActuateThera Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1885029946894020608.png) Actuate Therapeutics [@ActuateThera](/creator/twitter/ActuateThera) on x XX followers
Created: 2025-07-18 15:15:16 UTC

Dr. Andrew Mazar, Actuate’s Scientific Co-founder and COO, highlights the Company's positive Phase X trial results, positioning elraglusib a potential first-in-class therapy option for patients with refractory and resistant EWS. $ACTU

![](https://pbs.twimg.com/media/GwJjYLAWgAA0T8X.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946227277743731149/c:line.svg)

**Related Topics**
[$actu](/topic/$actu)

[Post Link](https://x.com/ActuateThera/status/1946227277743731149)